Status:
UNKNOWN
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
Leiomyoma
Eligibility:
FEMALE
20-50 years
Phase:
PHASE2
PHASE3
Brief Summary
The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of symptomatic uterine leiomyoma
Exclusion
- pregnancy
- iodine agent allergy
- patient refuse to take part in this trial
- tumour size is less than 3cm or beyond 10cm
- with endometriosis
- with malignant diseases
- with abnormal coagulation function which can't restore
- with acute inflammatory diseases or acute episode of chronic inflammatory diseases
- with severe heart, lung, liver and kidney, et al. organ diseases.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT00821275
Start Date
January 1 2008
End Date
December 1 2018
Last Update
January 13 2009
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital of Nanfang medical University
Guangzhou, Guangdong, China, 510000
2
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080
3
the first Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510089
4
Sun Yat-sen University
Guangzhou, Guangdong, China, 510630